MedPath

BioIntegrate

🇺🇸United States
Ownership
Private
Employees
-
Market Cap
-
Website

Umbilical Cord Derived Wharton's Jelly for Knee Osteoarthritis

Early Phase 1
Not yet recruiting
Conditions
Osteoarthritis, Knee
Interventions
Biological: Umbilical Cord-derived Wharton's Jelly
First Posted Date
2021-01-22
Last Posted Date
2022-07-21
Lead Sponsor
BioIntegrate
Target Recruit Count
12
Registration Number
NCT04719793

Evaluation of Safety and Efficacy of Wharton's Jelly Compared to Hyaluronic Acid and Saline for Knee Osteoarthritis.

Phase 1
Not yet recruiting
Conditions
Osteoarthritis, Knee
Interventions
Device: Hyaluronic acid
Other: Saline
Biological: Umbilical Cord-derived Wharton's Jelly
First Posted Date
2021-01-15
Last Posted Date
2022-07-21
Lead Sponsor
BioIntegrate
Target Recruit Count
168
Registration Number
NCT04711304

DualStim Therapy With or Without Umbilical Cord Derived Wharton's Jelly for Erectile Dysfunction

Phase 1
Not yet recruiting
Conditions
Erectile Dysfunction
Interventions
Device: DualStim Therapy
Other: Saline
Biological: Umbilical cord-derived Wharton's Jelly
First Posted Date
2020-06-11
Last Posted Date
2022-07-21
Lead Sponsor
BioIntegrate
Target Recruit Count
60
Registration Number
NCT04424394
© Copyright 2025. All Rights Reserved by MedPath